Imricor Medical Systems, Inc. (ASX:IMR)
1.395
+0.015 (1.09%)
At close: Dec 5, 2025
Imricor Medical Systems Revenue
Imricor Medical Systems had revenue of $196.88K USD in the half year ending June 30, 2025, a decrease of -1.07%. This brings the company's revenue in the last twelve months to $748.54K, down -9.19% year-over-year. In the year 2024, Imricor Medical Systems had annual revenue of $959.42K with 55.86% growth.
Revenue (ttm)
$748.54K
Revenue Growth
-9.19%
P/S Ratio
392.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
447.72M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 959.42K | 343.86K | 55.86% |
| Dec 31, 2023 | 615.57K | -200.44K | -24.56% |
| Dec 31, 2022 | 816.01K | 119.74K | 17.20% |
| Dec 31, 2021 | 696.27K | -5.89K | -0.84% |
| Dec 31, 2020 | 702.16K | 62.46K | 9.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |